Inside a Retatrutide Clinical Trial Experience: GLP-1s, HRT & Menopause Part 1

Resources for the Community:

___________________________________________________________________

https://linktr.ee/theplussidezpodcast 

Ro - Telehealth for GLP1 weight management 

https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55

Find Your US Representatives 

https://www.usa.gov/elected-officials 

______________________________________________________________________

We open with community member MiMi, who shares her experience participating in an Eli Lilly Retatrutide clinical trial, offering a rare, real-world look at this next-generation triple-agonist research. From there, we dive into how menopause and perimenopause reshape metabolism with insight from Dr. Komal Patil-Sisodia, an endocrinologist, obesity-medicine specialist, and midlife menopause expert. We explore how HRT and GLP-1 medications support symptoms, weight, and long-term health, what early research suggests about combining them, and why bone density, TMJ, and diabetes risk all matter in midlife care.

Follow Mimi

mimi_in_australia

Follow Dr. Patil 

drpatilsisodia

______________________________________________________________________

⭐️Mounjaro Stanley⭐️

griffintumblerco.Etsy.com

Use code PODCAST10 for $ OFF

______________________________________________________________________

Join this channel to get access to perks:

   / @theplussidez

______________________________________________________________________

#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories